Sort
39,280 grants matching “leukemia”
ARP--GENE TARGET OF THE ALL1 GENE IN ACUTE LEUKEMIAS
$357,897Thomas Jefferson University · R01 · FY2000 · CA
Core C: Survey Shared Resource Core
$357,871Jessica Chubak · Kaiser Foundation Research Institute · P01 · FY2020 · CA
Role of autophagy in normal and transformed hematopoietic stem cells
$357,814Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2016 · CA
Antileukemic effort of NK cells in HCT for pediatric AML
$357,812Wing Leung · St. Jude Children'S Research Hospital · R01 · FY2009 · CA
Impact of CREB-driven mechanism in shaping the tumor-immune landscape
$357,796Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R01 · FY2025 · CA
STUDIES ON VITAMIN D AND CALCIUM METABOLISM
$357,774University Of California Riverside · R01 · FY2004 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2021 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2022 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2023 · DK
Cholestatic Liver Injury
$357,750Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2020 · DK
Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes
$357,733Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Experimental Therapeutics
$357,713Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2016 · CA
A Civil Action" - Using the Landmark Trial for Learning Environmental Geoscience and the Connection Between Geology and Human Health
$357,653E. Scott Bair · Ohio State University Research Foundation -Do Not Use · · FY2005 · EDU
Targeted Alpha-particle Therapy
$357,651David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery
$357,650Michael R Verneris · University Of Colorado Denver · R01 · FY2017 · AI
MOLECULAR BASIS OF DROSOPHILA HOMEOTIC GENE REGULATION
$357,587Case Western Reserve University · R01 · FY2001 · GM
Role of Dok-1 in oncogenic tyrosine kinase signaling
$357,586Linda Van Aelst · Cold Spring Harbor Laboratory · R01 · FY2013 · CA
Polyploidy, aneuploidy and genome stability
$357,493David S Pellman · Dana-Farber Cancer Inst · R01 · FY2012 · GM
Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating
$357,493Patrick G. Harran · University Of California Los Angeles · R01 · FY2016 · CA
MODELING THE ROLE OF DIFFERENTIATION IN AML
$357,484Garry P Nolan · Stanford University · U54 · FY2012 · CA
MECHANISMS BY WHICH IFN-GAMMA SEPARATES GVHD AND GVL
$357,481Yong-Guang Yang · Columbia University Health Sciences · P01 · FY2010 · CA
Role of autophagy in normal and transformed hematopoietic stem cells
$357,460Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2015 · CA
Targeted- and timed-releasing nanotherapeutics against leukemia stem cells
$357,422Chong-Xian Pan · University Of California At Davis · R01 · FY2015 · CA
Polyploidy, aneuploidy and genome stability
$357,417David S Pellman · Dana-Farber Cancer Inst · R01 · FY2014 · GM
ALL therapy and developing brains: MRI measures, genetic factors and cognition
$357,411Wilburn E. Reddick · St. Jude Children'S Research Hospital · R01 · FY2013 · CA